We are a biotechnology company developing a donor-derived nipple areolar matrix for use in breast reconstruction that enables patients to regenerate a nipple made from their own cells that maintains projection, has natural pigmentation, and improved sensation.
Current reconstruction methods create a nipple that loses projection, has little to no sensation, and requires a tattoo for pigmentation.
NovoThelium has developed methods to process donor tissue to create a nipple areolar matrix. This matrix can be applied to the patient and cells from the patient can grow into the matrix to regenerate a nipple made from the patient's cells.
NovoThelium, co-founded by biomedical engineers with a family history of breast cancer, is working to revolutionize breast reconstruction using principles of regenerative medicine.